NCT05635929 2026-04-15
STOPOMP
Mucosa Innovations, S.L.
Phase NA Recruiting
Clinical Trials
61 trialsNCT07357597 2026-01-22
TROPION-SWISH
AstraZeneca
Phase 4 Not yet recruiting
NCT04651634 2025-04-06
MIT-001
MitoImmune Therapeutics
Phase 2 Active not recruiting
NCT06686602 2025-03-19
A Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast Cancer
Daiichi Sankyo
Completed
NCT05966194 2024-11-15
KEVLARx
EpicentRx, Inc.
Phase 2 Recruiting
NCT03515538 2024-11-04
PREVLAR
EpicentRx, Inc.
Phase 2 Completed
NCT06669390 2024-11-01
A Mouthwash Medicine for the Reduction or Prevention of Mouth Ulceration Caused by Radiotherapy for Head and Neck Cancer
VasoDynamics Ltd
Phase 1 Completed
NCT03972527 2024-08-21
Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients
MuReva Phototherapy Inc.
Phase NA Completed
NCT05493800 2024-05-29
Capella
MitoImmune Therapeutics
Phase 2 Active not recruiting
NCT05104268 2024-02-20
MDOM
E2Bio Life Sciences, LLC
Phase EARLY_PHASE1 Withdrawn
NCT03689712 2023-10-24
ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients
Galera Therapeutics, Inc.
Phase 3 Completed
NCT05994638 2023-10-13
Polyphenol Rich Aerosol as a Support for Cancer Patients in Minimizing Side Effects After a Radiation Therapy
AronPharma Sp. z o. o.
Phase NA Unknown
NCT04595838 2023-09-18
A Trial Assessing Chemo Mouthpiece Device With Best Supportive Care for Symptoms of Chemotherapy-Induced Oral Mucositis
Chemo Mouthpiece
Phase NA Completed
NCT03200340 2023-07-27
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
Enzychem Lifesciences Corporation
Phase 2 Completed
NCT04648020 2023-05-31
VOICE
Monopar Therapeutics
Phase 2/3 Terminated
NCT02229136 2022-12-01
Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus
US Oncology Research
Phase 2 Completed
NCT05055726 2022-11-16
BOOM
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase 4 Completed
NCT03237325 2022-11-08
DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
Soligenix
Phase 3 Completed
NCT04699487 2022-10-10
PrOMiSE
NeoMedLight
Phase NA Completed
NCT04529850 2022-08-16
Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer
Galera Therapeutics, Inc.
Phase 2 Completed
NCT02399228 2021-11-19
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Oral Mucositis
Santalis Pharmaceuticals, Inc.
Phase 2 Completed
NCT01288625 2021-11-17
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine
Sun Pharmaceutical Industries Limited
Phase 4 Withdrawn
NCT02508389 2021-09-20
A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer
Galera Therapeutics, Inc.
Phase 2 Completed
NCT01403064 2021-05-11
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
CSL Behring
Phase 2 Terminated
NCT03988556 2021-04-30
SafePBM
NeoMedLight
Phase NA Completed
NCT03234465 2020-11-23
Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day
Oragenics, Inc.
Phase 2 Terminated
NCT02542215 2019-12-02
Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy
Mallinckrodt
Phase 2 Terminated
NCT02606994 2019-02-06
TPvsM
Oral Defense, LLC
Phase 2 Terminated
NCT02324335 2019-01-16
Brilacidin
Innovation Pharmaceuticals, Inc.
Phase 2 Completed
NCT02885376 2018-12-21
Study of Dentoxol® Mouthrinse for Oral Mucositis
Ingalfarma SpA
Phase 2 Completed
NCT03577535 2018-08-01
Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.
Catalysis SL
Phase 2 Completed
NCT01400620 2018-03-13
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Izun Pharma Ltd
Phase 2 Completed
NCT02630004 2018-03-01
MUCOMEL
Spherium Biomed
Phase 1/2 Completed
NCT01385748 2017-11-28
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
Valerio Therapeutics
Phase 2 Completed
NCT02013050 2017-08-28
A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer
Soligenix
Phase 2 Completed
NCT00131638 2016-12-16
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer
Amgen
Phase 3 Completed
NCT00101582 2016-09-27
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
Swedish Orphan Biovitrum
Phase 3 Completed
NCT01921426 2016-09-22
A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck
Galera Therapeutics, Inc.
Phase 1 Completed
NCT01840436 2016-05-05
MUCIPLIQ
Organ, Tissue, Regeneration, Repair and Replacement
Phase NA Completed
NCT00323518 2016-04-13
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
Celldex Therapeutics
Phase 2 Completed
NCT00104065 2016-03-15
Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant
Celldex Therapeutics
Phase 2 Completed
NCT00434161 2015-03-30
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma
Swedish Orphan Biovitrum
Phase 3 Completed
NCT00460421 2014-12-05
A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT
Swedish Orphan Biovitrum
Phase 1 Completed
NCT00352703 2014-11-03
PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation
Swedish Orphan Biovitrum
Phase 4 Completed
NCT00189488 2014-09-15
Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation
Swedish Orphan Biovitrum
Phase 2 Completed
NCT00393822 2014-07-15
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer
Amgen
Phase 2/3 Completed
NCT01247246 2014-05-26
Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer
SciClone Pharmaceuticals
Phase 2 Unknown
NCT00938080 2014-01-07
Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck
ActoGeniX N.V.
Phase 1 Completed
NCT00574860 2013-09-20
EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer
Endo Pharmaceuticals
Phase 3 Terminated
NCT01283906 2013-09-12
MuGard
Access Pharmaceuticals, Inc.
Phase 4 Completed